Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-02-26 @ 12:42 AM
Study NCT ID:
NCT03872505
Status:
WITHDRAWN
Last Update Posted:
2021-08-25
First Post:
2019-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
Sponsor:
Cedars-Sinai Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-11
First Submit QC Date:
None
Study First Post Date:
2019-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-19
Last Update Post Date:
2021-08-25
Last Update Post Date Type:
ACTUAL